Torrent Pharmaceuticals redeems part of NCDs

Torrent Pharmaceuticals Ltd has announced that the Secured Redeemable Non-Convertible Debentures (NCDs) of Rs. 142.86 crores out of the total NCDs of Rs. 1000 crores issued under ISIN: INE685A07082 has been redeemed and repaid by the company on 14-Dec-23.

Laurus Synthesis receives Form 483 with 5 observations from USFDA

Laurus Synthesis Private Limited (LSPL), a wholly owned subsidiary of Laurus Labs underwent US FDA inspection for the manufacturing facility in Parawada, Anakapalli, near Visakhapatnam, Andhra Pradesh. The inspection was conducted from 4th December, 2023 to 12th December, 2023. We have been issued a Form 483 with five observations and the Company will address the observations within stipulated timelines.